North America Medicinal Mushroom Market

ID: MRFR/FnB/42884-HCR
200 Pages
Garvit Vyas
Last Updated: April 06, 2026
North America Medicinal Mushroom Market Size, Share, Industry Trend & Analysis Research Report: By Type (Shiitake, Reishi, Maitake, Chaga, Cordyceps, Turkey Tail, Other Types), By Form (Fresh, Dried, Other Form) and By Function (Antioxidant, Immune Enhancer, Anti-Cancer, Skin Care, Other Functions)- Forecast to 2035
North America Medicinal Mushroom Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)8.82%
2024 Market Size$ 1,500 Million
2025 Market Size$ 1,632.3 Million
2035 Market Size$ 3,800 Million
Key Players
Host Defense
Four Sigmatic
Om Mushroom Superfood
Real Mushrooms
Mushroom Wisdom
Fungi Perfecti
Trends
  • Rising Consumer Interest in Natural Remedies
  • Expansion of E-commerce Channels
  • Increased Research and Development
Opportunities
  • Support from Scientific Research
  • Increased Availability of Products
  • Shift Towards Preventive Healthcare
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Product Type (USD Million)
      1. 4.1.1 Shiitake
      2. 4.1.2 Lion's Mane
      3. 4.1.3 Reishi
      4. 4.1.4 Cordyceps
      5. 4.1.5 Chaga
      6. 4.1.6 Others
    2. 4.2 Pharmaceutical, BY Category (USD Million)
      1. 4.2.1 Organic
      2. 4.2.2 Conventional
    3. 4.3 Pharmaceutical, BY Form (USD Million)
      1. 4.3.1 Fresh
      2. 4.3.2 Processed
      3. 4.3.3 Dried
      4. 4.3.4 Powder
      5. 4.3.5 Others
    4. 4.4 Pharmaceutical, BY Application (USD Million)
      1. 4.4.1 Dietary Supplements
      2. 4.4.2 Food & Beverages
      3. 4.4.3 Personal Care
      4. 4.4.4 Pharmaceuticals
    5. 4.5 Pharmaceutical, BY End-user (USD Million)
      1. 4.5.1 Residential
      2. 4.5.2 Commercial
    6. 4.6 Pharmaceutical, BY Distribution Channel (USD Million)
      1. 4.6.1 Supermarkets & Hypermarkets
      2. 4.6.2 Specialty Stores
      3. 4.6.3 E-commerce
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Host Defense (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Four Sigmatic (FI)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Om Mushroom Superfood (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Real Mushrooms (CA)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Mushroom Wisdom (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Fungi Perfecti (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Mushroom Science (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Mycoformulas (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
    3. 6.3 NORTH AMERICA MARKET ANALYSIS BY CATEGORY
    4. 6.4 NORTH AMERICA MARKET ANALYSIS BY FORM
    5. 6.5 NORTH AMERICA MARKET ANALYSIS BY APPLICATION
    6. 6.6 NORTH AMERICA MARKET ANALYSIS BY END-USER
    7. 6.7 NORTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    8. 6.8 KEY BUYING CRITERIA OF PHARMACEUTICAL
    9. 6.9 RESEARCH PROCESS OF MRFR
    10. 6.10 DRO ANALYSIS OF PHARMACEUTICAL
    11. 6.11 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    12. 6.12 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    13. 6.13 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    14. 6.14 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 PHARMACEUTICAL, BY CATEGORY, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY CATEGORY, 2024 TO 2035 (USD Million)
    18. 6.18 PHARMACEUTICAL, BY FORM, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY FORM, 2024 TO 2035 (USD Million)
    20. 6.20 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
    21. 6.21 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
    22. 6.22 PHARMACEUTICAL, BY END-USER, 2024 (% SHARE)
    23. 6.23 PHARMACEUTICAL, BY END-USER, 2024 TO 2035 (USD Million)
    24. 6.24 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    25. 6.25 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    26. 6.26 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY CATEGORY, 2025-2035 (USD Million)
      3. 7.2.3 BY FORM, 2025-2035 (USD Million)
      4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
      5. 7.2.5 BY END-USER, 2025-2035 (USD Million)
      6. 7.2.6 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

North America North America Medicinal Mushroom Market Segmentation

North America Medicinal Mushroom Market By Product Type (USD Million, 2025-2035)

  • Shiitake
  • Lion's Mane
  • Reishi
  • Cordyceps
  • Chaga
  • Others

North America Medicinal Mushroom Market By Category (USD Million, 2025-2035)

  • Organic
  • Conventional

North America Medicinal Mushroom Market By Form (USD Million, 2025-2035)

  • Fresh
  • Processed
  • Dried
  • Powder
  • Others

North America Medicinal Mushroom Market By Application (USD Million, 2025-2035)

  • Dietary Supplements
  • Food & Beverages
  • Personal Care
  • North America Medicinal Mushroom Markets

North America Medicinal Mushroom Market By End-user (USD Million, 2025-2035)

  • Residential
  • Commercial

North America Medicinal Mushroom Market By Distribution Channel (USD Million, 2025-2035)

  • Supermarkets & Hypermarkets
  • Specialty Stores
  • E-commerce

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.